Skip to main content
Premium Trial:

Request an Annual Quote

GrassRoots, Monsanto Extend Deal for Development of Gene Promoters for Crop Yield

NEW YORK (GenomeWeb News) – GrassRoots Biotechnology and Monsanto today announced the extension of an agreement for the development of gene promoters to enhance and protect crop yields.

The original three-year deal between the two firms has been extended two years and now runs through January 2014.

Monsanto expects to use expression elements sourced from GrassRoots "to optimize an array of biotechnology traits in a broad range of crops, including corn, soy, cotton, and canola," the companies said. They added that the agricultural biotechnology industry has relied on promoters discovered between 20 and 30 years ago that cannot provide the required levels of precise and tissue-specific control of gene expression for the development of the next generation of biotechnology crops that can withstand biotic and abiotic stresses.

The deal provides GrassRoots access to Monsanto's product development and marketing know-how, which could hasten GrassRoots' commercialization of its promoters.

The Durham, NC-based company's promoter discovery approach is based on computational biology for the "generation and analysis of high-resolution expression datasets from both model systems and commercial crops." The promoters are characterized by the company's RootArray technology, which allows researchers to monitor gene expression in the roots in 3D over time and under different environmental conditions.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.